Batch report · Janoshik Analytical

Retatrutide 20mg Pen COA — RET-20-C-2604-001

ProPeptide Retatrutide 20mg Pen

Analysed 23 April 20261 reportHPLC purity 99.841%

ProPeptide Retatrutide 20mg Pen, batch RET-20-C-2604-001. On the Janoshik Analytical reports, testing was ordered on 22 April 2026, the sample was received on 22 April 2026 and analysis was conducted on 23 April 2026.

Janoshik issued one report:

  • HPLC purity & concentration 99.841% · 22.51 mg/mL task 150762 · 23 Apr 2026

Each report has its own verification key, listed below with a link to the laboratory’s copy.

For in-vitro laboratory research only. Not for human or veterinary use.

Batch facts

Product
ProPeptide Retatrutide Pen 20mg (exact format)
Batch
RET-20-C-2604-001
Sample (as printed)
Retatrutide 20mg
Manufacturer / brand
ProPeptide
Strength / format
20mg pen cartridge
Laboratory
Janoshik Analytical (opens in a new tab)
Testing ordered
22 April 2026
Sample received
22 April 2026
Analysed
23 April 2026
Reports
1

Verify each report

One row per Janoshik report. “Verify on Janoshik” opens the laboratory’s own copy for that task and key; the key can also be entered at janoshik.com/verification (opens janoshik.com in a new tab).

RET-20-C-2604-001 — Janoshik reports, task numbers and verification keys
TestResultAnalysedTaskVerification keyLaboratory copy
HPLC purity & concentrationRequested as: Common GLP-1 peptide blind test (Semaglutide, Tirzepatide and Retatrutide) - for the cartridge 99.841% · 22.51 mg/mL 23 Apr 2026 #150762 Verify on Janoshik — HPLC purity & concentration, task 150762 (opens janoshik.com in a new tab) Janoshik test report, task 150762: HPLC purity & concentration for ProPeptide Retatrutide 20mg Pen, batch RET-20-C-2604-001

Report comments

Printed in the “Comments” field of the report, quoted as written.

Report scans

The report images as published for this batch, shown uncropped. Select a scan to open it at full size.

Related product and lab resources